Plasma nicotinic acid levels in hemodialysis patients after the administration of niceritrol

Japanese Journal of Nephrology

Volumn 41, Issue 4, 1999, Pages 430-435

  Saika, Yasushi ^a  

^a Ryoushukai Fujii Hospital   (Japan)

Author keywords

Blood nicotinic acid concentration; Hemodialysis; Niceritrol; Variable renal diseases

Indexed keywords

LIPOPROTEIN A; NICERITROL; NICOTINIC ACID;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; RISK FACTOR;

ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEIN(A); NIACIN; NICERITROL; RENAL DIALYSIS; RISK FACTORS;

EID: 0032791698     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Rostand SG, Brunzell JD, Cannon R. Cardiovascular complications in renal failure(ed). J Am Sco Nephrol 1991 ; 2 : 1053-1062.
2. Berg K. A new serum type system in man the Lp system. Acta Path 1963 ; 59 : 369-382.
3. Rosengren A, Wihelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease : a prospective case-control study in a general population sample of middle aged men. BMJ 1990 ; 301 : 1248-1251.
4. McLean JM, Tomlinson JE. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987 ; 300 : 132-137.